A detailed history of ETF Managers Group, LLC transactions in Vaxxinity, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 43,836 shares of VAXX stock, worth $438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,836
Previous 31,427 39.49%
Holding current value
$438
Previous $43,000 130.23%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$1.43 - $4.24 $17,744 - $52,614
12,409 Added 39.49%
43,836 $99,000
Q4 2022

Mar 23, 2023

SELL
$1.31 - $2.62 $7,548 - $15,096
-5,762 Reduced 15.49%
31,427 $43,000
Q3 2022

Nov 14, 2022

SELL
$1.64 - $2.48 $4,291 - $6,490
-2,617 Reduced 6.57%
37,189 $74,000
Q2 2022

Aug 15, 2022

BUY
$1.55 - $6.95 $3,045 - $13,656
1,965 Added 5.19%
39,806 $62,000
Q1 2022

May 13, 2022

SELL
$3.7 - $8.6 $159 - $369
-43 Reduced 0.11%
37,841 $167,000
Q4 2021

Feb 14, 2022

BUY
$5.55 - $18.46 $210,256 - $699,338
37,884 New
37,884 $211,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.